{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:22:44Z","timestamp":1790871764133,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Natural Science Foundation of Hebei Province","award":["H2019206191"],"award-info":[{"award-number":["H2019206191"]}]},{"name":"The Natural Science Foundation of Hebei Province","award":["H2021206161"],"award-info":[{"award-number":["H2021206161"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00011-021-01533-3","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T19:04:01Z","timestamp":1642705441000},"page":"243-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO\/NR4A3 axis"],"prefix":"10.1007","volume":"71","author":[{"given":"Yan-Bing","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5281-9291","authenticated-orcid":false,"given":"Wei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"1533_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/cvr\/cvy023","volume":"114","author":"RM Touyz","year":"2018","unstructured":"Touyz RM, Alves-Lopes R, Rios FJ, et al. Vascular smooth muscle contraction in hypertension. Cardiovasc Res. 2018;114:529\u201339.","journal-title":"Cardiovasc Res"},{"key":"1533_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","volume":"94","author":"S Patel","year":"2017","unstructured":"Patel S, Rauf A, Khan H, et al. Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed Pharmacother. 2017;94:317\u201325.","journal-title":"Biomed Pharmacother"},{"key":"1533_CR3","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/CIRCRESAHA.118.313207","volume":"123","author":"S Das","year":"2018","unstructured":"Das S, Zhang E, Senapati P, et al. A novel angiotensin II-induced long noncoding RNA giver regulates oxidative stress, inflammation, and proliferation in vascular smooth muscle cells. Circ Res. 2018;123:1298\u2013312.","journal-title":"Circ Res"},{"key":"1533_CR4","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.bbadis.2015.04.012","volume":"1852","author":"Z Yang","year":"2015","unstructured":"Yang Z, Zheng B, Zhang Y, et al. miR-155-dependent regulation of mammalian sterile 20-like kinase 2 (MST2) coordinates inflammation, oxidative stress and proliferation in vascular smooth muscle cells. Biochim Biophys Acta. 2015;1852:1477\u201389.","journal-title":"Biochim Biophys Acta"},{"key":"1533_CR5","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254\u201370.","journal-title":"Hepatology"},{"key":"1533_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Weng H, Su R, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase. Cancer Cell. 2017;31:127\u201341.","journal-title":"Cancer Cell"},{"key":"1533_CR7","doi-asserted-by":"crossref","unstructured":"Mizuno TM. Fat mass and obesity associated (FTO) Gene and Hepatic Glucose and Lipid Metabolism. Nutrients 2018, 10.","DOI":"10.20944\/preprints201810.0166.v1"},{"key":"1533_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fonc.2019.00369","volume":"9","author":"ZX Rong","year":"2019","unstructured":"Rong ZX, Li Z, He JJ, et al. Downregulation of fat mass and obesity associated (FTO) promotes the progression of intrahepatic cholangiocarcinoma. Front Oncol. 2019;9:369.","journal-title":"Front Oncol"},{"key":"1533_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00125-008-1186-6","volume":"52","author":"CS Yajnik","year":"2009","unstructured":"Yajnik CS, Janipalli CS, Bhaskar S, et al. FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians. Diabetologia. 2009;52:247\u201352.","journal-title":"Diabetologia"},{"key":"1533_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7150\/thno.31562","volume":"9","author":"L Sun","year":"2019","unstructured":"Sun L, Ma L, Zhang H, et al. Fto Deficiency reduces anxiety- and depression-like behaviors in mice via alterations in gut microbiota. Theranostics. 2019;9:721\u201333.","journal-title":"Theranostics"},{"key":"1533_CR11","doi-asserted-by":"crossref","unstructured":"Wei J, Liu F, Lu Z, et al. Differential m(6)A, m(6)Am, and m(1)A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm. Mol Cell 2018,71:973\u2013985 e975.","DOI":"10.1016\/j.molcel.2018.08.011"},{"key":"1533_CR12","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.1002\/jcb.26746","volume":"119","author":"H Kang","year":"2018","unstructured":"Kang H, Zhang Z, Yu L, et al. FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation. J Cell Biochem. 2018;119:5676\u201385.","journal-title":"J Cell Biochem"},{"key":"1533_CR13","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/cr.2014.151","volume":"24","author":"X Zhao","year":"2014","unstructured":"Zhao X, Yang Y, Sun BF, et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 2014;24:1403\u201319.","journal-title":"Cell Res"},{"key":"1533_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12935-019-1045-1","volume":"19","author":"D Zou","year":"2019","unstructured":"Zou D, Dong L, Li C, et al. The m(6)A eraser FTO facilitates proliferation and migration of human cervical cancer cells. Cancer Cell Int. 2019;19:321.","journal-title":"Cancer Cell Int"},{"key":"1533_CR15","doi-asserted-by":"crossref","unstructured":"Zhu B, Gong Y, Shen L, et al. Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP\/p16 signals via m(6)A modulation. Biomed Pharmacother 2020,124:109935.","DOI":"10.1016\/j.biopha.2020.109935"},{"key":"1533_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.bcp.2011.06.002","volume":"82","author":"S D'Alessandro","year":"2011","unstructured":"D\u2019Alessandro S, Basilico N, Corbett Y, et al. Hypoxia modulates the effect of dihydroartemisinin on endothelial cells. Biochem Pharmacol. 2011;82:476\u201384.","journal-title":"Biochem Pharmacol"},{"key":"1533_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.vph.2004.11.001","volume":"41","author":"GD Wu","year":"2004","unstructured":"Wu GD, Zhou HJ, Wu XH. Apoptosis of human umbilical vein endothelial cells induced by artesunate. Vascul Pharmacol. 2004;41:205\u201312.","journal-title":"Vascul Pharmacol"},{"key":"1533_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1043-6618(03)00107-5","volume":"48","author":"HH Chen","year":"2003","unstructured":"Chen HH, Zhou HJ, Fang X. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol Res. 2003;48:231\u20136.","journal-title":"Pharmacol Res"},{"key":"1533_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1254\/jjp.40.239","volume":"40","author":"S Okabe","year":"1986","unstructured":"Okabe S, Higaki E, Higuchi T, et al. Biochemical and pharmacological analysis of 2-[(2-dimethylaminobenzyl)sulfinyl] benzimidazole (NC-1300), a new proton pump inhibitor. Jpn J Pharmacol. 1986;40:239\u201349.","journal-title":"Jpn J Pharmacol"},{"key":"1533_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.vph.2007.05.002","volume":"47","author":"HJ Zhou","year":"2007","unstructured":"Zhou HJ, Wang WQ, Wu GD, et al. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells. Vascul Pharmacol. 2007;47:131\u20138.","journal-title":"Vascul Pharmacol"},{"key":"1533_CR21","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.4161\/15384047.2014.955728","volume":"15","author":"F Dong","year":"2014","unstructured":"Dong F, Zhou X, Li C, et al. Dihydroartemisinin targets VEGFR2 via the NF-kappaB pathway in endothelial cells to inhibit angiogenesis. Cancer Biol Ther. 2014;15:1479\u201388.","journal-title":"Cancer Biol Ther"},{"key":"1533_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/HYPERTENSIONAHA.115.05280","volume":"66","author":"XH Zhang","year":"2015","unstructured":"Zhang XH, Zheng B, Yang Z, et al. TMEM16A and myocardin form a positive feedback loop that is disrupted by KLF5 during Ang II-induced vascular remodeling. Hypertension. 2015;66:412\u201321.","journal-title":"Hypertension"},{"key":"1533_CR23","first-page":"1415809","volume":"2019","author":"N Li","year":"2019","unstructured":"Li N, Sun W, Zhou X, et al. Dihydroartemisinin protects against dextran sulfate sodium-induced colitis in mice through inhibiting the PI3K\/AKT and NF-kappaB signaling pathways. Biomed Res Int. 2019;2019:1415809.","journal-title":"Biomed Res Int"},{"key":"1533_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-017-0531-3","volume":"36","author":"F Zhang","year":"2017","unstructured":"Zhang F, Ma Q, Xu Z, et al. Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer. J Exp Clin Cancer Res. 2017;36:68.","journal-title":"J Exp Clin Cancer Res"},{"key":"1533_CR25","doi-asserted-by":"publisher","first-page":"62460","DOI":"10.18632\/oncotarget.11517","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Wang Y, Kong R, et al. Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network. Oncotarget. 2016;7:62460\u201373.","journal-title":"Oncotarget"},{"key":"1533_CR26","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/s41388-018-0602-8","volume":"38","author":"Z Yang","year":"2019","unstructured":"Yang Z, Qu CB, Zhang Y, et al. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene. 2019;38:2516\u201332.","journal-title":"Oncogene"},{"key":"1533_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bbrc.2019.03.093","volume":"512","author":"J Li","year":"2019","unstructured":"Li J, Han Y, Zhang H, et al. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA. Biochem Biophys Res Commun. 2019;512:479\u201385.","journal-title":"Biochem Biophys Res Commun"},{"key":"1533_CR28","doi-asserted-by":"crossref","unstructured":"Su R, Dong L, Li C, et al. R-2HG Exhibits Anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling. Cell 2018, 172:90\u2013105 e123.","DOI":"10.1016\/j.cell.2017.11.031"},{"key":"1533_CR29","doi-asserted-by":"crossref","unstructured":"Ma D, Liu X, Zhang JJ, et al. Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Front Cardiovasc Med 2020, 7:592550.","DOI":"10.3389\/fcvm.2020.592550"},{"key":"1533_CR30","doi-asserted-by":"crossref","unstructured":"Munoz-Durango N, Fuentes CA, Castillo AE, et al. Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension. Int J Mol Sci 2016, 17.","DOI":"10.3390\/ijms17070797"},{"key":"1533_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/HYPERTENSIONAHA.111.187021","volume":"59","author":"EL Schiffrin","year":"2012","unstructured":"Schiffrin EL. Vascular remodeling in hypertension: mechanisms and treatment. Hypertension. 2012;59:367\u201374.","journal-title":"Hypertension"},{"key":"1533_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.tips.2008.05.003","volume":"29","author":"C Marchesi","year":"2008","unstructured":"Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci. 2008;29:367\u201374.","journal-title":"Trends Pharmacol Sci"},{"key":"1533_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/01.mnh.0000203190.34643.d4","volume":"15","author":"M Ruiz-Ortega","year":"2006","unstructured":"Ruiz-Ortega M, Esteban V, Ruperez M, et al. Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens. 2006;15:159\u201366.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1533_CR34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","volume":"126","author":"AL Bookout","year":"2006","unstructured":"Bookout AL, Jeong Y, Downes M, et al. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell. 2006;126:789\u201399.","journal-title":"Cell"},{"key":"1533_CR35","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm1579","volume":"13","author":"SE Mullican","year":"2007","unstructured":"Mullican SE, Zhang S, Konopleva M, et al. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat Med. 2007;13:730\u20135.","journal-title":"Nat Med"},{"key":"1533_CR36","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.2337\/db09-0763","volume":"58","author":"LC Chao","year":"2009","unstructured":"Chao LC, Wroblewski K, Zhang Z, et al. Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes. 2009;58:2788\u201396.","journal-title":"Diabetes"},{"key":"1533_CR37","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1210\/en.2007-1202","volume":"149","author":"MA Pearen","year":"2008","unstructured":"Pearen MA, Myers SA, Raichur S, et al. The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology. 2008;149:2853\u201365.","journal-title":"Endocrinology"},{"key":"1533_CR38","doi-asserted-by":"crossref","unstructured":"Tessem JS, Moss LG, Chao LC, et al. Nkx6.1 regulates islet beta-cell proliferation via Nr4a1 and Nr4a3 nuclear receptors. Proc Natl Acad Sci U S A 2014, 111:5242\u20135247.","DOI":"10.1073\/pnas.1320953111"},{"key":"1533_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mce.2009.05.006","volume":"309","author":"SA Myers","year":"2009","unstructured":"Myers SA, Eriksson N, Burow R, et al. Beta-adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues. Mol Cell Endocrinol. 2009;309:101\u20138.","journal-title":"Mol Cell Endocrinol"},{"key":"1533_CR40","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1126\/science.1925541","volume":"252","author":"TE Wilson","year":"1991","unstructured":"Wilson TE, Fahrner TJ, Johnston M, et al. Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science. 1991;252:1296\u2013300.","journal-title":"Science"},{"key":"1533_CR41","doi-asserted-by":"crossref","unstructured":"Herring JA, Elison WS, Tessem JS. Function of Nr4a orphan nuclear receptors in proliferation, apoptosis and fuel utilization across tissues. Cells 2019, 8.","DOI":"10.3390\/cells8111373"},{"key":"1533_CR42","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1161\/ATVBAHA.109.191163","volume":"30","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Bruemmer D. NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler Thromb Vasc Biol. 2010;30:1535\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1533_CR43","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.bbrc.2020.07.095","volume":"530","author":"B Yang","year":"2020","unstructured":"Yang B, Gao X, Sun Y, et al. Dihydroartemisinin alleviates high glucose-induced vascular smooth muscle cells proliferation and inflammation by depressing the miR-376b-3p\/KLF15 pathway. Biochem Biophys Res Commun. 2020;530:574\u201380.","journal-title":"Biochem Biophys Res Commun"},{"key":"1533_CR44","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00380-018-1190-9","volume":"33","author":"J Yin","year":"2018","unstructured":"Yin J, Xia W, Zhang Y, et al. Role of dihydroartemisinin in regulating prostaglandin E2 synthesis cascade and inflammation in endothelial cells. Heart Vessels. 2018;33:1411\u201322.","journal-title":"Heart Vessels"},{"key":"1533_CR45","doi-asserted-by":"crossref","unstructured":"Liu X, Lu J, Liao Y, et al. Dihydroartemisinin attenuates lipopolysaccharide-induced acute kidney injury by inhibiting inflammation and oxidative stress. Biomed Pharmacother 2019, 117:109070.","DOI":"10.1016\/j.biopha.2019.109070"},{"key":"1533_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/FJC.0000000000000672","volume":"73","author":"X Xu","year":"2019","unstructured":"Xu X, Jiang R, Chen M, et al. Puerarin decreases collagen secretion in angii-induced atrial fibroblasts through inhibiting autophagy via the JNK-Akt-mTOR signaling pathway. J Cardiovasc Pharmacol. 2019;73:373\u201382.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1533_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.yexcr.2018.01.012","volume":"363","author":"BC Chen","year":"2018","unstructured":"Chen BC, Shibu MA, Kuo CH, et al. E4BP4 inhibits AngII-induced apoptosis in H9c2 cardiomyoblasts by activating the PI3K-Akt pathway and promoting calcium uptake. Exp Cell Res. 2018;363:227\u201334.","journal-title":"Exp Cell Res"},{"key":"1533_CR48","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.2147\/OTT.S283417","volume":"13","author":"JY Wang","year":"2020","unstructured":"Wang JY, Chen LJ, Qiang P. The Potential role of N6-methyladenosine (m6A) demethylase fat mass and obesity-associated gene (FTO) in human cancers. Onco Targets Ther. 2020;13:12845\u201356.","journal-title":"Onco Targets Ther"},{"key":"1533_CR49","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.7150\/jca.33704","volume":"10","author":"J Liu","year":"2019","unstructured":"Liu J, Ren Y, Hou Y, et al. Dihydroartemisinin induces endothelial cell autophagy through suppression of the Akt\/mTOR pathway. J Cancer. 2019;10:6057\u201364.","journal-title":"J Cancer"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-021-01533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-021-01533-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-021-01533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T02:08:17Z","timestamp":1643422097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-021-01533-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1007\/s00011-021-01533-3","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"16 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}